What You Should Know:
– Cleerly, a leader in AI-based cardiovascular imaging, has announced that Cigna will begin covering its Cleerly LABS Advanced Plaque Analysis starting on October 1, 2025.
– The decision makes Cigna the latest major insurer to recognize the clinical and economic value of Artificial Intelligence Enabled CT Based Quantitative Coronary Tomography (AI-QCT) and Coronary Plaque Analysis (AI-CPA) technology for cardiovascular care.
Widespread Payer Adoption and Coverage Details
With over 16 million covered lives, Cigna joins UnitedHealthcare and EviCore in providing Cleerly’s advanced imaging technology. Combined with Medicare’s 2024 coverage decision and an upcoming CPT I code in January 2026, AI-QCT/AI-CPA technology is now covered for over 61 million Americans.
Beginning October 1, 2025, all Cigna health plans will cover AI-QCT/AI-CPA imaging for patients who meet specific clinical criteria:
- The patient has acute or stable chest pain with no known coronary artery disease (CAD) and is eligible for CCTA.
- The CCTA classifies the patient as intermediate risk, or CAD-RADS 1, 2, or 3 category.
- The cardiac evaluation is negative or inconclusive for acute coronary syndrome (ACS).
“We’re witnessing a fundamental transformation in cardiovascular care,” said James K. Min, MD, founder and CEO of Cleerly. “Major insurers now recognize that advanced plaque analysis through our AI-QCT technology enhances clinical insights and supports clinicians in making more informed care decisions. This represents a pivotal moment for precision medicine in cardiology.”
